Free Trial

Trellus Health (TRLS) Competitors

GBX 2 +0.35 (+21.21%)
As of 04/30/2025 11:34 AM Eastern

TRLS vs. INHC, FDBK, IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, and RENX

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Renalytix (RENX). These companies are all part of the "health information services" industry.

Trellus Health vs.

Induction Healthcare Group (LON:INHC) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, community ranking, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

In the previous week, Induction Healthcare Group's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
Induction Healthcare Group Neutral
Trellus Health Neutral

Induction Healthcare Group received 14 more outperform votes than Trellus Health when rated by MarketBeat users.

CompanyUnderperformOutperform
Induction Healthcare GroupOutperform Votes
14
93.33%
Underperform Votes
1
6.67%
Trellus HealthN/AN/A

46.3% of Induction Healthcare Group shares are held by institutional investors. Comparatively, 19.3% of Trellus Health shares are held by institutional investors. 54.6% of Induction Healthcare Group shares are held by insiders. Comparatively, 49.7% of Trellus Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Induction Healthcare Group has a beta of -0.41, suggesting that its share price is 141% less volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500.

Induction Healthcare Group has higher revenue and earnings than Trellus Health. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Induction Healthcare Group£12.57M0.71-£5.12M-£5.54-1.75
Trellus Health£65.83K58.73-£7.98M-£3.45-0.58

Induction Healthcare Group has a net margin of -40.70% compared to Trellus Health's net margin of -12,114.55%. Induction Healthcare Group's return on equity of -26.97% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Induction Healthcare Group-40.70% -26.97% -7.32%
Trellus Health -12,114.55%-37.95%-22.76%

Summary

Induction Healthcare Group beats Trellus Health on 8 of the 12 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£3.87M£204.68M£5.57B£2.56B
Dividend YieldN/A6.68%5.11%4.84%
P/E Ratio-0.58219.8722.44132.42
Price / Sales58.73471.47394.10240,284.86
Price / Cash0.7647.1438.1828.16
Price / Book0.215.196.774.55
Net Income-£7.98M-£15.55M£3.22B£5.85B
7 Day Performance24.22%0.94%1.48%2.57%
1 Month Performance-4.31%0.59%3.99%8.70%
1 Year Performance2.72%8.99%16.20%113.17%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 2
+21.2%
N/A+11.1%£3.87M£65,831.01-0.5831Gap Down
INHC
Induction Healthcare Group
N/AGBX 9.60
+1.1%
N/A-26.8%£8.86M£12.57M-1.7374Positive News
High Trading Volume
FDBK
Feedback
N/AGBX 17.10
-2.3%
N/A-84.7%£7.49M£3.88M-0.6924Gap Down
IQAI
IQ-AI
N/AGBX 0.85
+1.2%
N/A-40.9%£1.87M£538,190.00-13.676Earnings Report
News Coverage
Gap Down
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
3.1496 of 5 stars
GBX 1,578.50
-0.1%
GBX 2,800
+77.4%
-15.5%£678.23M£230.77M58.32734Insider Trade
News Coverage
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500Positive News
KOO
Kooth
N/AGBX 153.95
+1.3%
GBX 456.67
+196.6%
-49.6%£56.50M£50.72M14.46478
RENX
Renalytix
N/AGBX 8.39
+4.9%
N/A-60.5%£34.78M£9.22M-0.40102Gap Up

Related Companies and Tools


This page (LON:TRLS) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners